Archive
Barclays is the next bank under the spotlight
Barclays and Ted Baker are the notable names in the diary for Wednesday.
Company
LON:GNS
Genus's principal activity is the global application of quantitative genetics and biotechnology to animal breeding. The company operates in five operating segments: North America, Latin America, Europe, Far East, and research and development. The research and development segment includes research, bovine product development and porcine product development,
46 stories · page 2 of 3
Archive
Barclays and Ted Baker are the notable names in the diary for Wednesday.
The bull and pig semen company said its Chinese operations have been hit by falling pig prices and lower volumes
Boss Stephen Wilson said recent volatility in the Chinese porcine market "is expected to continue for some months, creating a short-term headwind" in the new financial year
Adjusted profit before tax is expected to come in at £47-49mln for the six months to December 31
The animal genetics specialist said trading is “ahead of expectations” and that it is likely to perform better than its previous profit growth forecasts for the 2021 financial year
Hardware & electrical equipment
The FTSE 250 “looks cheap” relative to its blue-chip sibling and should outperform during the new UK lockdown, the analysts reckon
Analysts said the Chinese market rebound is likely to offset the short-term issues in the US which are currently persisting
The litigation forms part of a long-running dispute between ABS Global Inc, Inguran, and Cytonome over the development and launch of Genus' sexed semen technology
Revenue from the porcine business was flat even though there were fewer animal shipments in China as African Swine Fever killed pigs
The AFS epidemic is keeping a lid on Genus’ near-term profits, but longer-term, Liberum expects pig prices and production to soar
The placing proceeds will ensure balance sheet flexibility to continue to invest in the business and to take advantage of infill acquisition opportunities, Peel Hunt analysts said
A look at the day's major movers, featuring AJ Bell, Genus, CyanConnode, EVR Holdings, Quadrise Fuels and ImmuPharma
The placing price represents a 7.8% discount to the closing price of 2,386p on 6 December 2018
Kepler Chevreux analyst said that in the short term, it regards African swine fever as a manageable one-off that Genus can cope with
"The successful launch of Sexcel, our innovative proprietary 21st century sexed semen product in September 2017, was a real highlight after many years of pioneering development"
With around half-an-hour of trading to go in London, the FTSE100 index was almost 20 points lower at 7,282, the day’s worst levels, well below an earlier peak of 7,310.
Archive
Will Barclays' results be duff, like HSBC's, or buff, like Lloyds'?
Electrical retailer set to report higher sales despite EU referendum uncertainty